Robert Alan Oster

Dr. Robert Alan Oster

University of Alabama at Birmingham
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2010 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
PPPeter George Pappas
Peter George Pappas
BABarbara D. Alexander
Barbara D. Alexander
DADavid Andes
David Andes
SHSusan Hadley
Susan Hadley
CKCarol A. Kauffman
Carol A. Kauffman
TCTom M. Chiller
Tom M. Chiller
Background. Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among organ transplant recipients. Multicenter prospective surveillance data to determine disease burden and secular trends are lacking.

15 June 2010 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JBJohn W. Baddley
John W. Baddley
DADavid Andes
David Andes
KMKieren A. Marr
Kieren A. Marr
DKDimitrios P. Kontoyiannis
Dimitrios P. Kontoyiannis
BABarbara D. Alexander
Barbara D. Alexander
PPPeter G. Pappas
Peter G. Pappas
Background. Invasive aspergillosis (IA) is an important cause of morbidity and mortality in hematopoietic stem cell transplant (HSCT) and solid organ

1 June 2008 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
ATAshita Jiwat Jiwat Tolwani
Ashita Jiwat Jiwat Tolwani
RCRuth C. Campbell
Ruth C. Campbell
BSBrenda S. Stofan
Brenda S. Stofan
KLK. Robin Lai
K. Robin Lai
RORobert Alan Oster
Robert Alan Oster
KWKeith M. Wille
Keith M. Wille
The effect of dosage of continuous venovenous hemodiafiltration (CVVHDF) on survival in patients with acute renal failure (ARF) is unknown. In this study, 200 critically ill patients with ARF were randomly assigned to receive CVVHDF with prefilter replacement fluid at an effluent rate of either 35 ml/kg per h (high dosage) or 20 ml/kg per h (standard dosage). The primary study outcome, survival to the earlier of either intensive care unit discharge or 30 d, was 49% in the high-dosage arm and 56% in the standard-dosage arm (odds ratio 0.75; 95% confidence interval 0.43 to 1.32; P = 0.32). Among hospital survivors, 69% of those in the high-dosage arm recovered renal function compared with 80% of those in the standard-dosage arm (P = 0.29); therefore, a difference in patient survival or renal recovery was not detected between patients receiving high-dosage or standard-dosage CVVHDF.

1 September 2009 in Journal of Critical Care
Verified
Journal Article
Closed access
LHLeslie W. Hayes
Leslie W. Hayes
RORobert Alan Oster
Robert Alan Oster
NTNancy M. Tofil
Nancy M. Tofil
ATAshita J. Tolwani
Ashita J. Tolwani

1 May 2008 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JBJ. W. Baddley
J. W. Baddley
JPJ. R. Perfect
J. R. Perfect
RORobert Alan Oster
Robert Alan Oster
RLR. A. Larsen
R. A. Larsen
GPG. A. Pankey
G. A. Pankey
PPP. G. Pappas
P. G. Pappas

1 March 2006 in Fertility and Sterility
Verified
Journal Article
Closed access
CDCrystal Douglas
Crystal Douglas
BGBarbara A. Gower
Barbara A. Gower
BDBetty E. Darnell
Betty E. Darnell
FOFernando Ovalle
Fernando Ovalle
RORobert Alan Oster
Robert Alan Oster
RARicardo Azziz
Ricardo Azziz